MED-EL ELEKTROMEDIZINISCHE GERAETE GMBH

Manufacturer adverse-event records for MED-EL ELEKTROMEDIZINISCHE GERAETE GMBH come from the U.S. Food & Drug Administration (FDA) MAUDE database via openFDA, refreshed March 2026 - see our methodology. Not medical advice.

FDA MAUDE device safety record · 2001–2026 · mid-book · quiet Death-code · balanced

Death-code intensity

MED-EL ELEKTROMEDIZINISCHE GERAETE GMBH is quieter on Death-coded events

Death-coded event_type rows are 4 of 13,599 (0.03% · quiet tercile among 443 manufacturers). Absolute volume is mid-book.

What the Death-code reading shows for MED-EL ELEKTROMEDIZINISCHE GERAETE GMBH

The standout signal for MED-EL ELEKTROMEDIZINISCHE GERAETE GMBH is Death-code intensity: 0.03% of 13,599 reports (quiet tercile), while absolute volume is mid-book.

Mid-pack volume still shows a clear device fingerprint; the table below is the actionable layer for MED-EL ELEKTROMEDIZINISCHE GERAETE GMBH. Event_type Death/Injury codes differ from patient-outcome rows - see methodology.

Reports span 10 device types, led in this extract by Malfunction at 7,083 (52.1% of event_type total). Peak single-year volume reaches 1,254 reports across 26 years. These are raw FDA submissions, not adjudicated findings. Snapshot . Verify current communications on the FDA MDR page.

13,599
Total Reports
4
Event-type Death
6,454
Injury Reports
10
Device Types

Event Types

Malfunction 7,083 (52.1%)
Injury 6,454 (47.5%)
Other 49 (0.4%)
9 (0.1%)
Death 4 (0.0%)

Patient Outcomes

FDA patient-outcome codes (separate from event_type). Percentages use this chart's row total.

Required Intervention 9,833 (73.1%)
3,441 (25.6%)
R 60 (0.4%)
Hospitalization 58 (0.4%)
H 25 (0.2%)
L 16 (0.1%)
Life Threatening 8 (0.1%)
Other 6 (0.0%)
Death 5 (0.0%)
Congenital Anomaly 2 (0.0%)
D 1 (0.0%)
S 1 (0.0%)

Yearly Trend

01
2001: 11
02
2002: 63
03
2003: 163
04
2004: 85
05
2005: 57
06
2006: 82
07
2007: 48
08
2008: 113
09
2009: 197
10
2010: 179
11
2011: 243
12
2012: 177
13
2013: 200
14
2014: 253
15
2015: 744
16
2016: 915
17
2017: 1,113
18
2018: 1,051
19
2019: 1,027
20
2020: 890
21
2021: 1,161
22
2022: 1,006
23
2023: 1,172
24
2024: 1,182
25
2025: 1,254
26
2026: 213